Crown Bioscience Netherlands BV

Crown Bioscience Netherlands BV is a company in Leiden, Netherlands that has taken part in 9 EU-funded projects since 2017, receiving €2.2M in EU funding and leading 1 as coordinator.

EU funding received€2.2M
EU projects9
As coordinator1
Running now4
First EU project2017
Latest project2027
CountryNetherlands
EU registration (PIC)888741646
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Crown Bioscience Netherlands BV's own share of each project, not the project's full budget.

  • Horizon Europe€1.2M · 4 projects
  • Horizon 2020€981k · 5 projects

Projects

9 EU-funded projects, newest first. Crown Bioscience Netherlands BV led 1 of them as coordinator. Each links to the official record.

  • dIscOverNETPartner

    Developing Immune Strategies to Counter tumor-immune-micrOnVironmEntal Resistance in NeuroEndocrine Tumors.

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €611ktheir share
  • FOCUS-4RPartner

    Fostering Outermost regions Capabilities in Research and Innovation and Upgrading Skills complying with 4R principles

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €96ktheir share
  • BRECISEPartner

    Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €481ktheir share
  • Maxima ButterflyAssociated partner

    From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • DRUGtrainPartner

    Drug repurposing and discovery multidisciplinary training network

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €266ktheir share
  • TRIM-NETPartner

    Training network in drug discovery targeting TRIM Ubiquitin ligases in disease

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • EDIReXPartner

    EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €255ktheir share
  • 3DPDCoordinator

    PhD position in commercial environment: cancer immunotherapy drug screening in 3D

    Horizon 2020 · 2017–2018 · Project on CORDIS ↗

    €135ktheir share
  • TransQSTPartner

    Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €325ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • artificial intelligence
  • bladder cancer
  • cardiac arrhythmia
  • cell biology
  • colorectal cancer
  • commerce
  • drug discovery
  • drug safety
  • ecosystems
  • entrepreneurship
  • immunotherapy
  • mutation
  • neurobiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime